M42’s Healthpoint expands
its plastic and
reconstructive surgery
offering with
multidisciplinary care for
specialized medical
disorders
(ABU DHABI)
-
Healthpoint, part of the
M42
group, is
enhancing its plastic and
reconstructive surgery
services with a
multidisciplinary focus on
treating specialized chronic
disorders like lipedema and
lymphedema. These
conditions, often
characterized by abnormal
fat or fluid accumulation,
lead to chronic and
uncomfortable swelling. The
new services integrate
advanced diagnostics and
treatment methods,
incorporating cutting-edge
artificial intelligence (AI)
and technology to deliver
personalized patient care.
Key differences
between lymphedema and
lipedema are:
-
Lymphedema is
caused by a
malfunctioning lymphatic
system, preventing
proper lymph fluid
drainage. It can be
primary (genetically
inherited) or secondary,
often triggered by
factors like lymph node
removal, radiation
therapy, injuries,
and severe obesity.
Lymphedema is
particularly common in
breast cancer patients
who have undergone lymph
node removal or
radiation. Research
indicates that around
20
percent of breast cancer
patients are at risk of
developing lymphedema
after surgery.
-
Lipedema is
characterized by
abnormal fat
distribution, usually in
the lower body, and is
linked to genetic
factors, hormonal
imbalances, or obesity.
It predominantly affects
women, with the National
Institutes of Health
(NIH) estimating that
nearly
11 percent of
adult women worldwide
have lipedema.
When assessing lymphedema, the
Healthpoint team evaluates
the extent of lymphatic
fluid retention and tissue
damage and identifies the
point of blockage in the
lymphatic channels to create
tailored treatment plans.
These may include
non-surgical conservative or
physiological treatment that
redirects lymphatic fluid
drainage by connecting
lymphatic vessels with
venous vessels to bypass
blockages or re-implanting
lymph nodes. In advanced
lymphedema cases,
conservative liposuction
removes tissue without
harming remaining lymphatic
vessels. Understanding the
severity of one’s condition
is crucial for effective
management and prevention of
disease progression.
Dr. Nahla Al
Mansoori, Department Head of
the Plastic and
Reconstructive Surgery at
Healthpoint, said:
“The expansion of
Healthpoint’s plastic and
reconstructive surgery
offering reflects our
commitment to providing
patient-centric care. These
new services treat
specialized medical
disorders and align with
M42’s vision to
revolutionize healthcare
with advanced and
comprehensive AI
technology-driven solutions.
The enhancement of our
services reaffirms
Healthpoint’s dedication to
improving the lives of
individuals affected by
these challenging
conditions.”
By
incorporating personalized
care plans and utilizing the
latest medical advancements,
Healthpoint aims to improve
the quality of life for
individuals affected by
lipedema and lymphedema.
PRINT
THIS ARTICLE
|